MAPS Public Benefit Corporation

About MAPS Public Benefit Corporation

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a nonprofit organization dedicated to creating legal, responsible, and evidence-based pathways to psychedelics. Founded in 1986, MAPS focuses on ending psychedelic prohibition through research, education, and advocacy, aiming to make psychedelics and marijuana safely and legally available for beneficial uses while prioritizing public benefit over profit.

Products & Services

Psychedelic-Assisted Therapy Research:MAPS has incubated advanced research into psychedelic-assisted therapies, particularly MDMA, with the potential for government approval in the US.

Psychedelic Education:MAPS offers educational resources and hosts the largest psychedelic science conference, accessible via the Virtual Trip platform with nearly 500 videos.

Policy Reform and Advocacy:MAPS advocates for policy changes to end drug prohibition and supports the rights and dignity of individuals using psychedelics without stigma.

Harm Reduction (Zendo Project):MAPS provides harm reduction resources and peer support through The Zendo Project to ensure safety in psychedelic therapy.

Published Titles and Merchandise:MAPS offers books on psychedelics (e.g., 'LSD My Problem Child', 'The Ketamine Papers'), apparel, and accessories through their store.

Specialties

Psychedelic-Assisted Therapy MDMA Research Psychedelic Education Policy Reform Harm Reduction Research on Marijuana, LSD, Ibogaine, and Ayahuasca

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 100000000 MR: - FA: 1亿美元 FAN: 100000000	D: 2024-01-12 FD: 2024-01-12	-
2	RT: Grant T: - FT: Grant	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2023-06-22 FD: 2023-06-22	1 investors

Series A Latest

2024-01-12

$100.0M

Grant 2023-06-22

$5.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rick Doblin

Founder and President

A

Alise Agar

D

Debby Harlow

A

Amy Emerson

Drug Development Expert

D

David Bronner

Board of Directors

V

Vicky Dulai

Board Chair

View 7 more team members with Pro

Unlock Full Team Directory

Recent News